Cohort StudyNCIt concept

https://sesstim.univ-amu.fr/fr/video-box/seminaire-interne-christel-protiere
2023
France
audiovisual aids
Additional Molecular Studies Were Not Performed
Regional Anesthesia was not Administered
RET Rearrangement Analysis Was Not Performed
BRAF Rearrangement Analysis Was Not Performed
Adjuvant Post-operative Chemotherapy Was Not Administered
Tumor Progression Absent After Initial Treatment
Sex
Adjuvant I-131 Therapy Negative
Chemical/Occupational Exposure Absent
KRAS Mutation Analysis Was Not Performed
MET Mutation Analysis Was Not Performed
PTEN Mutation Analysis Was Not Performed
NRAS Mutation Analysis Was Not Performed
Peripheral Blood Immunophenotyping and Cytochemistry Were Not Performed
KIT Mutation Analysis Was Not Performed
Local Anesthesia Agents were not Administered
Norway
IDH Family Mutation Analysis Was Not Performed
Another Form of Birth Control was not Used
NON Mouse
No Known History of Alcohol Use
Nitric Oxide Measurement
NF1 Mutation Analysis Was Not Performed
PDGFRA Mutation Analysis Was Not Performed
Preoperative IV Opiates were not Administered
Diversity
ALK Rearrangement Analysis Was Not Performed
Targeted Molecular Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
Sex Behavior
EGFR Gene Amplification Negative
MGMT Promoter Methylation Testing Was Not Performed
TP53 Mutation Analysis Was Not Performed
SDH Complex Mutation Analysis Was Not Performed
CDISC SDTM Sex of Individual Terminology
Preoperative IV Antiemetics were not Administered
Fluorescence In Situ Hybridization Was Not Performed
Chief Complaint Not Caused by Trauma
Lymph Node Dissection Was Not Performed
Any Metastatic Diagnosis Absent
New Disease is not Multifocal
drug users
Preoperative IV Sedation was Not Administered
attentiveness
Therapeutic Ionizing Radiation to Head History Absent
Adjuvant Post-operative Radiation Therapy Was Not Administered
ATRX Gene Mutation Negative
No History of Congenital Heart Disease
Intercurrent Illness is Absent at Onset of Chief Complaint
IDH Family Wildtype
Radiation Was Not Administered as an Additional Treatment for a New Tumor Event
No History of Rheumatic Fever
Application Context
Analysis
Other Preoperative IV Medications were not Administered
analysis, cohort
Documentation Absent
History of Colorectal Cancer Negative
Bone Marrow Aspirate Immunophenotyping and Cytochemistry Were Not Performed
Twice
Minor Criteria for Rheumatic Heart Disease Not Present
Additional Surgery for New Metastatic Tumor Event Was Not Performed
Family History of Stomach Cancer Absent
Chemotherapy Not Received
Physician Diagnosed Diabetes Absent
Immunotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
First Degree Family History of Primary Brain Tumor Negative
First Degree Family History Cancer Negative
Hypertension Absent
Outcome Assessment, Health Care
Adjuvant Post-operative Immunological Therapy Was Not Administered
Patient was Not Previously Evaluated for Current Chief Complaint
BRAF Mutation Analysis Was Not Performed
Additional Surgery for New Tumor Event Absent
EGFR Amplification Analysis Was Not Performed
Intervention Not Given for Kawasaki Disease
Additional Immunohistochemistry Was Not Performed
Analyzed
No Response to Intervention for Kawasaki Disease
Routine Cytogenetics Were not Completed
Paraneoplastic Syndrome is Not Present
cohort studies
Not Lost to Follow-Up
No History of Gestational Complication
Interferon Gamma Treatment was not Administered Prior to Specimen Resection
Cancer History Absent
Patient was not Postmenopausal with no Prior Oophorectomy
No History of Other Muscular Dystrophy or Glycogen Storage Disorder
Nitric Oxide
Caffeine Not Routinely Consumed
ROS1 Rearrangement Analysis Was Not Performed
No History of Non-Cardiac Surgery
10q23/PTEN Locus Deletion Analysis Was Not Performed
Unemployed
History of Medical Treatment Absent
Radiation Therapy Not Received
Adjuvant Post-operative Targeted Molecular Therapy Was Not Administered
Additional Surgery for New Loco-Regional Tumor Event Was Not Performed
Chemotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
ATRX Mutation Analysis Was Not Performed
Use of Smokeless Tobacco at Time of Diagnosis Negative
Has No Sibling
First Degree Family History Thyroid Cancer Negative
New Tumor Event After Initial Treatment Absent
Interferon Gamma Treatment was not Administered 90 Days Prior to Specimen Resection
Neither
Regular Smokeless Tobacco Use for Six Weeks or More Negative
Comparison
Multiple Known Primary Tumors Absent at Initial Melanoma Diagnosis
drugged state
1p/19q Deletion Analysis Was Not Performed
Cohort Study
Neither Case or Control Status
Adjuvant Post-operative Pharmaceutical Therapy Was Not Administered
No History of Kawasaki Disease
Radiation History Negative
Tumor Reoccurrence Absent After Initial Treatment
ERBB2 Mutation Analysis Was Not Performed
resulting in
Evidence of Disease Absent after Completion of Therapy
No Known History of Illicit Drug Use
Medication Not Taken
Preoperative IV Antacids were not Administered
Chief Complaint was Not Witnessed
Negation
Subsequent Known Primary Melanoma(s) Not Found During the Follow-Up
IV Anesthesia was not Administered
EGFR Mutation Analysis Was Not Performed
No History of Myopathy
Hormone Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
No History of Neonatal Complication
PTEN Gene Mutation Negative

---
https://www.santepubliquefrance.fr/maladies-et-traumatismes/sante-mentale/depression-et-anxiete/documents/enquetes-etudes/etat-de-sante-des-travailleurs-et-consequences-professionnelles-durant-le-premier-confinement-du-printemps-2020-resultats-issus-de-la-cohorte-con
2023
France
technical report
Spring Device
Louisiana
health personnel
Health Status
NT5E wt Allele
Health Professional
Cohort Study
SSB wt Allele
Lupus Anticoagulant Antibody
Spring
resulting in
Lao People's Democratic Republic
Essential Thrombocythemia
Beyond
Andorra
Endotracheal Route of Administration
health status
containment of biohazards
Lower Esophageal Sphincter
Left Arm
Entity Name Data Type
Lanthanum
Docetaxel/Epirubicin Regimen
Drinking Status
Health Care Professional
Ethiopia

---
https://dumas.ccsd.cnrs.fr/dumas-04222221
2023
France
dissertations, academic
Clinical Study Follow-up
adolescent
Health Care Professional Promotional Material
Topical Route of Administration
High Level
Value Above Reference Range
Youth
Topical Dosage Form
IPSS-R Risk Category High
Cohort Study
High Mitosis-Karyorrhexis Index
Autonomic Nervous System
Follow
general practitioners
Professional Occupation
aftercare
General Qualifier
Determine
High-Frequency Microsatellite Instability
IPSS Risk Category High

---